Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02460341 · ClinicalTrials.gov registry record · Phase 1
The Effects of Ondansetron on Brain Function
A Phase 1 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
NCT02460341 is a Phase 1 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 54 participants.
The verdict
NCT02460341, a Phase 1 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
This project investigates the effects of a single dose of ondansetron on brain function in healthy adults. The investigators hypothesize that there will be a dose-dependent reduction in activation of the insula and somatosensory brain regions associated with the use of ondansetron.
Interventions
- DRUG placebo
- DRUG ondansetron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-02-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02460341
The ClinicalTrials.gov registry entry for NCT02460341 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02460341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02460341 about?
NCT02460341 is a clinical study titled "The Effects of Ondansetron on Brain Function". This project investigates the effects of a single dose of ondansetron on brain function in healthy adults. The investigators hypothesize that there will be a dose-dependent reduction in activation of the insula and somatosensory brain regions associated with the use of ondansetron.
What is the current status of trial NCT02460341?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2015-08. Estimated completion is 2017-02-03.
What interventions are being tested in trial NCT02460341?
The interventions under investigation include: placebo (DRUG), ondansetron (DRUG).
Who is sponsoring clinical trial NCT02460341?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.